Profile
David Lasecki worked as a Senior Director-Oncology Sales at Heron Therapeutics, Inc. and as a Chief Commercialization Officer at GenomOncology LLC.
He also briefly worked as an Executive Director-Strategic Alliances at Cellectar Biosciences, Inc. Mr. Lasecki completed his undergraduate degree at the University of Mount Union.
Former positions of David Lasecki
| Companies | Position | End |
|---|---|---|
| CELLECTAR BIOSCIENCES, INC. | Corporate Officer/Principal | 31/10/2022 |
| HERON THERAPEUTICS, INC. | Corporate Officer/Principal | - |
GenomOncology LLC
 GenomOncology LLC Packaged SoftwareTechnology Services GenomOncology LLC develops technology for genetic information. The firm provides knowledge-enabled workflows to support clinical decision making across precision medicine programs. Its tailored workflows empower clinical laboratories, medical informatics initiatives, oncologists and multi-disciplinary teams to guide patient treatment, while gaining and applying insights to optimize cancer care. The firm's products include clinical oncology, molecular pathology, cancer informatics. The company was founded by Manuel J. Glynias in 2012 and is headquartered in Cleveland, OH. | Corporate Officer/Principal | - |
Training of David Lasecki
| University of Mount Union | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| CELLECTAR BIOSCIENCES, INC. | Health Technology |
| HERON THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
GenomOncology LLC
GenomOncology LLC Packaged SoftwareTechnology Services GenomOncology LLC develops technology for genetic information. The firm provides knowledge-enabled workflows to support clinical decision making across precision medicine programs. Its tailored workflows empower clinical laboratories, medical informatics initiatives, oncologists and multi-disciplinary teams to guide patient treatment, while gaining and applying insights to optimize cancer care. The firm's products include clinical oncology, molecular pathology, cancer informatics. The company was founded by Manuel J. Glynias in 2012 and is headquartered in Cleveland, OH. | Technology Services |
- Stock Market
- Insiders
- David Lasecki
